• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

TAVR Vs Standard Surgery: Midterm Stroke, Death Rates Comparable
All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to results from the PARTNER study presented at the American College of Cardiology's 62nd Annual Scientific Session. The transcatheter aortic valve replacement (TAVR) system was investigated as an alternative to open-heart surgery for high-risk patients with severe aortic stenosis - narrowing of a main circulatory gateway in the heart that reduces blood flow...
Source: Health News from Medical News Today - March 14, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Medtronic heart valve found to reduce death, stroke rate
(Reuters) - Medtronic Inc's CoreValve heart valve implant significantly lowered death and stroke rates in frail, elderly patients with severe aortic stenosis who were considered too ill for surgery, according to data from a late-stage clinical trial.
Source: Reuters: Health - October 29, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

COREVALVE reduces rate of death and stroke in sickest patients with aortic stenosis
In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing death and stroke in patients with severe aortic stenosis at "extreme risk" for surgery. Results of the COREVALVE EXTREME RISK trial were presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine...
Source: Health News from Medical News Today - October 31, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Personalizing Medicine: Considering Preferences and Values
If you're interested in heart disease -- and who over the age of 40 isn't? -- you may have read an excellent series of articles by reporter Gina Kolata recently published in the New York Times. If you haven't seen it, the series includes pieces on blood pressure, stents, heart attack treatment and a new approach to aortic valve replacement. The heart valve article especially caught my eye, as this is a story I've been watching with personal interest: My 90-year-old mother has aortic stenosis for which surgery has been recommended. In fact, surgery was first recommended for my mom at least six years ago. I know that timing ...
Source: Healthy Living - The Huffington Post - July 10, 2015 Category: Consumer Health News Source Type: news

Survival and Stroke Similar for TAVR and SAVR at 5 Years Survival and Stroke Similar for TAVR and SAVR at 5 Years
The early mortality benefit seen with transcatheter aortic valve replacement over surgical repair in patients with severe aortic stenosis at high surgical risk is no longer significant at 5 years.Medscape Medical News
Source: Medscape Medical News Headlines - November 26, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

CoreValve High-Risk Study at 3 Years: TAVR Advantage SustainedCoreValve High-Risk Study at 3 Years: TAVR Advantage Sustained
In this high-risk population with severe aortic stenosis, patients were less likely to die or have a stroke within 3 years if they had percutaneous rather than surgical valve replacement. Heartwire from Medscape
Source: Medscape Medical News Headlines - April 15, 2016 Category: Consumer Health News Tags: Cardiology News Source Type: news

NOTION: 5-Year TAVR vs SAVR Outcomes Similar in Low-Risk Patients NOTION: 5-Year TAVR vs SAVR Outcomes Similar in Low-Risk Patients
All-cause mortality, MI, and stroke were similar in low-risk patients with severe aortic stenosis who had transcatheter aortic valve replacement and those who had surgery, but 42% of TAVR patients needed pacemakers.Medscape Medical News
Source: Medscape Medical News Headlines - April 9, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

PARTNER 3: TAVR Success in Low-Risk Patients PARTNER 3: TAVR Success in Low-Risk Patients
The procedure using the SAPIEN 3 valve showed a significantly lower rate of death, stroke, and rehospitalization at 1 year vs surgery in patients with severe aortic stenosis at low surgical risk.Medscape Medical News
Source: Medscape Medical News Headlines - March 16, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news